Understanding the intricate web of biological interactions in cancer is challenging due to the sheer complexity and scale of the networks involved. Network segmentation allows researchers to focus on specific pathways and interactions, making it easier to identify key drivers of cancer. This targeted approach can reveal critical insights about how cancer cells evade the immune system, proliferate uncontrollably, and develop resistance to therapies. By breaking down these networks, scientists can develop more effective, personalized treatment strategies.
